Validity of mobility lab (version 2) for gait assessment in young adults, older adults and Parkinson's disease

Rosie Morris, Samuel Stuart, Grace Mcbarron, Peter C. Fino, Martina Mancini, Carolin Curtze

Research output: Contribution to journalArticlepeer-review

114 Scopus citations

Abstract

Objective: Gait provides a sensitive measurement for signs of aging and neurodegenerative conditions. Measurement of gait is transitioning from the laboratory environment to the clinic with the use of inertial measurement units, providing a simple and cost-effective assessment tool. However, such assessments first need validation against reference systems. The aim of this study was to validate the APDM Mobility Lab (ML) system (version 2) against a pressure sensor walkway in younger adults (n = 18), older adults (n = 18) and people with mild Parkinson's disease (n = 21) in the laboratory. Approach: Participants completed a two-minute walk over a pressure sensor walkway whilst wearing three sensors (strapped to the lumbar spine and both feet). Comparison of output from the systems was then performed. Main results: Overall, we identified that ML provided good to excellent agreement (ICC > 0.75) for gait velocity, stride length, stride length SD, cadence, stride time and stride time SD. Measures of double support time, single support time and swing time had moderate to poor agreement (ICC 0.213-0.725), particularly for younger adults and PD. Significance: Overall, Mobility Lab provides a valid system for gait data collection for clinical and research application.

Original languageEnglish (US)
Article number095003
JournalPhysiological Measurement
Volume40
Issue number9
DOIs
StatePublished - Sep 26 2019

Keywords

  • Gait
  • Inertial measurement unit
  • Instrumented walkway
  • Parkinson's disease
  • Validation

ASJC Scopus subject areas

  • Biophysics
  • Physiology
  • Biomedical Engineering
  • Physiology (medical)

Fingerprint

Dive into the research topics of 'Validity of mobility lab (version 2) for gait assessment in young adults, older adults and Parkinson's disease'. Together they form a unique fingerprint.

Cite this